Canonic Logo

Canonic to Present at CannX, 4th International Medical Cannabis Conference in Tel Aviv

 Canonic, a fully owned subsidiary of Evogene Ltd. developing medical cannabis products, Dr. Arnon Heyman, Canonic’s CEO, will present at CannX, 4th International Medical Cannabis Conference in Tel Aviv, September 9-10, 2019. Dr. Heyman will be participating in a session on “Cannabis Genetics – New Developments“, and his presentation will focus on precise genomics for medical cannabis and take place on Monday, September 9th, at 12:20.  

Investors attending the conference who wish to meet with Dr. Heyman, may contact Evogene’s Investor Relations team at ir@evogene.com.